Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...

A week after an announcement made by Biden's office about former US President's undergoing medical care, Joe Biden rang a ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

A new study underway at St. David’s Surgical Hospital could help men recover faster and live a better quality of life after ...

In hormone-sensitive prostate cancer, an alternative dosing of docetaxel plus Nubeqa and ADT was associated with improvements in side effect rates.

GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...

Fresh from a European cancer conference that was all about antibody-drug conjugates (ADCs), GSK has turned to French biotech ...

The National Institute for Health and Care Excellence (NICE) has recommended darolutamide in combination with androgen ...

Grape seed extract—a dietary supplement made from the seeds of wine grapes—has been investigated to see if it can help reduce ...

Two-thirds of American men will have noticeable hair loss by age 35, with some 85% having significantly thinning hair by age ...